CS logo
small CS logo
DOM- Centro de Reumatologia

Caba, Buenos Aires, Argentina
Rheumatologist in Buenos Aires
Ayacucho 1246 1º Piso, C1111 CABA

About DOM- Centro de Reumatologia


"Primer Centro de Reumatología en Recoleta especializado en enfermedades autoinmunes y reumatológicas con un enfoque interdisciplinario que brinda atención integral en clínica médica, dermatología, endocrinología, nutrición, traumatología y reumatología pediátrica."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at DOM- Centro de Reumatologia


During the past decade, DOM- Centro de Reumatologia conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "DOM- Centro de Reumatologia" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Nektar Therapeutics" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at DOM- Centro de Reumatologia


According to Clinical.Site data, the most researched conditions in "DOM- Centro de Reumatologia" are "Systemic Lupus Erythematosus" (3 trials), "Crohn's Disease" (2 trials), "Atopic Dermatitis" (1 trials), "Colitis, Ulcerative" (1 trials) and "Systemic Lupus Erythematosus (SLE)" (1 trials). Many other conditions were trialed in "DOM- Centro de Reumatologia" in a lesser frequency.

Clinical Trials Intervention Types at DOM- Centro de Reumatologia


Most popular intervention types in "DOM- Centro de Reumatologia" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Baricitinib" (2 trials), "LY3471851" (2 trials), "Mirikizumab" (2 trials) and "LY3375880" (1 trials). Other intervention names were less common.

Clinical Trials Genders at DOM- Centro de Reumatologia


The vast majority of trials in "DOM- Centro de Reumatologia" are 8 trials for "All" genders.

Clinical Trials Status at DOM- Centro de Reumatologia


Currently, there are NaN active trials in "DOM- Centro de Reumatologia". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DOM- Centro de Reumatologia, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in DOM- Centro de Reumatologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of DOM- Centro de Reumatologia


DOM- Centro de Reumatologia has several departments that took part in Clinical trials: "DOM Centro de Reumatología" - 3 trials